Aryavan Enterprise Q4 FY26 Results: Net Profit ₹1.2 Cr, Up 50.0% YoY
Aryavan Enterprise Ltd reported revenue from operations of ₹25.4 Cr (+78.9% YoY) and net profit of ₹1.2 Cr (+50.0% YoY) for Q4 FY26.
- Key figure
- Net profit ₹1.2 Cr · +50.0% YoY
ALFA Filings
Every announcement, straight from the exchange
Every financial results announcement on NSE and BSE that our alert engine sent, newest first.
Time
16,741 announcements with these filters
Aryavan Enterprise Ltd reported revenue from operations of ₹25.4 Cr (+78.9% YoY) and net profit of ₹1.2 Cr (+50.0% YoY) for Q4 FY26.
Samyak International reported audited FY26 results with consolidated revenue of ₹45.62 Crore. The company posted a consolidated net profit of ₹0.24 Crore for the year.
Ecofinity Atomix Limited approved audited financial results for the year ended March 31, 2026. The board confirmed an unmodified audit report from statutory auditors.
Silverline Technologies Ltd reported revenue from operations of ₹3.4 Cr (-89.5% YoY) and a net loss of ₹26.4 Cr for Q4 FY26.
Evoq Remedies Limited reported audited financial results for the year ended March 31, 2026. The auditor issued a qualified opinion citing material uncertainty regarding going concern.
Gennex Laboratories Ltd reported revenue from operations of ₹61 Cr (+51.4% YoY) and net profit of ₹4.5 Cr (+45.2% YoY) for Q4 FY26.
Silverline Technologies reported Audited Financial Results for FY26. The Board also approved shifting its registered office to Mumbai and appointed new independent directors.
Gennex Laboratories reported a consolidated total income of ₹180.99 Crore for FY26. The Board approved audited results despite a qualified opinion regarding unconfirmed asset and liability balances.
Skybiotech Healthcare Ltd reported revenue from operations of ₹1.8 Cr (+80.0% YoY) and a net loss of ₹0.3 Cr for Q4 FY26.
Maiden Forgings Limited reported annual revenue of ₹231.61 Crore for FY26. Net profit stood at ₹5.02 Crore, reflecting stable operational performance for the fiscal year.
Omni Ax's Software Ltd reported a net loss of ₹0.1 Cr for Q4 FY26.
Integrated Hitech Ltd reported a net loss of ₹0.1 Cr for Q4 FY26.
Skybiotech Healthcare Limited approved its audited standalone and consolidated financial results for the fiscal year ending March 31, 2026. The board meeting concluded with an unmodified audit opinion.
Omni Axs Software approved audited standalone financial results for the year ended March 31, 2026. The company reported a net loss of ₹5.55 Lakhs for the period.
Integrated Hitech Limited approved its audited financial results for FY2026 during a board meeting on May 30, 2026. The company also appointed Nitin Oza as internal auditor.
Samyak International Ltd reported revenue from operations of ₹10.4 Cr (-23.0% YoY) and a net loss of ₹2.5 Cr for Q4 FY26.
Veerkrupa Jewellers Ltd reported revenue from operations of ₹34.9 Cr (+66.2% YoY) and net profit of ₹0.1 Cr (-50.0% YoY) for H2 FY26.
Samyak International Ltd reported consolidated annual revenue of ₹42.26 Crore for FY2025-26. The board approved audited results with an unmodified opinion from statutory auditors.
Veerkrupa Jewellers reported audited FY26 results with total income of ₹59.39 Crore. Auditors issued a qualified opinion regarding inadequate inventory records and internal controls.
Apis India Ltd reported revenue from operations of ₹97.9 Cr (+8.5% YoY) and net profit of ₹10.3 Cr (+27.2% YoY) for Q4 FY26.
Shreenath Paper Products Ltd reported revenue from operations of ₹59.3 Cr (+19.1% YoY) and net profit of ₹2.1 Cr (+10.5% YoY) for H2 FY26.
Apis India Limited reported audited financial results for the year ended March 31, 2026. The board also appointed new statutory auditors and a National Sales Head.
Shreenath Paper Products approved its audited financial results for the year ended March 31, 2026. The company also re-appointed Mr. Navneetdas Parekh as Chief Financial Officer.
Ortin Global Ltd reported net profit of ₹0 Cr for Q4 FY26.
Ortin Global Limited reported a total income of ₹0.41 Crore for FY26. The company posted a net loss of ₹0.74 Crore for the full year.
Panorama Studios International Ltd reported revenue from operations of ₹64.8 Cr (-69.5% YoY) and net profit of ₹7.2 Cr (-76.8% YoY) for Q4 FY26.
Panorama Studios reported annual standalone revenue of ₹307.75 Crore for FY26. The Board approved audited results and confirmed an unmodified auditor's opinion.
Aarey Drugs & Pharmaceuticals Ltd reported revenue from operations of ₹189.5 Cr (+75.3% YoY) and net profit of ₹1.6 Cr (+220.0% YoY) for Q4 FY26.
Konark Synthetics Ltd reported revenue from operations of ₹12.2 Cr (-23.8% YoY) and a net loss of ₹0.1 Cr for Q4 FY26.
Aarey Drugs & Pharmaceuticals approved audited standalone financial results for FY26. The board also recorded a statement of no deviation in the utilization of preferential issue funds.